| AASLD

Respiratory risk score for the prediction of 3‐month mortality and prolonged ventilation after liver transplantation

Read more about Respiratory risk score for the prediction of 3‐month mortality and prolonged ventilation after liver transplantation

Moritz Kleine, Florian W. R. Vondran, Kai Johanning, Kai Timrott, Hüseyin Bektas, Frank Lehner, Juergen Klempnauer, Harald Schrem – 21 May 2013 – Survival of critically ill patients is significantly affected by prolonged ventilation. The goal of this study was the development of a respiratory risk score (RRS) for the prediction of 3‐month mortality and prolonged ventilation after liver transplantation (LT). Two hundred fifty‐four consecutive LT patients from a single center were retrospectively randomized into a training group for model design and a validation group.

Recurrent upper gastrointestinal bleeding masquerading as gastric variceal bleeding on endoscopy after liver transplantation

Read more about Recurrent upper gastrointestinal bleeding masquerading as gastric variceal bleeding on endoscopy after liver transplantation

Ibrahim A. Hanouneh, Bradley D. Confer, Nizar N. Zein, Naim Alkhouri, Bijan Eghtesad – 21 May 2013

Selection and outcomes of living donors with a remnant volume less than 30% after right hepatectomy

Read more about Selection and outcomes of living donors with a remnant volume less than 30% after right hepatectomy

Seong Hoon Kim, Young Kyu Kim, Seung Duk Lee, Sang‐Jae Park – 21 May 2013 – The evidence for defining a safe minimal remnant volume after living donor hepatectomy is insufficient. The aim of this study was to evaluate the outcomes of living donors with a remnant/total volume ratio (RTVR) < 30% after right hepatectomy according to the following selection criteria: the preservation of the middle hepatic vein (MHV), an age < 50 years, and no or mild fatty changes in healthy adults.

Decreasing Incidence of Symptomatic Epstein‐Barr Virus Disease and Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients: Report of the Studies of Pediatric Liver Transplantation Experience

Read more about Decreasing Incidence of Symptomatic Epstein‐Barr Virus Disease and Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients: Report of the Studies of Pediatric Liver Transplantation Experience

Michael R. Narkewicz, Michael Green, Stephen Dunn, Michael Millis, Susan McDiarmid, George Mazariegos, Ravinder Anand, Wanrong Yin, Studies of Pediatric Liver Transplantation Research Group – 21 May 2013 – Posttransplant lymphoproliferative disorder (PTLD) causes significant morbidity and mortality in pediatric recipients of liver transplantation (LT). Objective: Describe the incidence of PTLD and symptomatic Epstein‐Barr virus (SEBV) disease in a large multicenter cohort of children who underwent LT with a focus on the risk factors and changes in incidence over time.